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The rising prevalence of diabetes mellitus (DM) and its association with tuberculosis (TB) and the persistence is 
a major public health problem worldwide, especially in developing countries,thus emphasizing the importance 
of investigating this association. This study was aimed at investigating the prevalence of Diabetes mellitus II 
and impaired fasting glycaemia in patients diagnosed with pulmonary TB at the Bamenda Regional Hospital .An 
experimental and prospective design, involving 91 patients diagnosed of pulmonary TB and 68 sputum negative 
patients were used as control. Venous blood was collected from each participant and was analyzed using the 
CHRONO LAB system chemistry analyzer to screen for impaired fasting glycaemia and Diabetes mellitus. 
Information to assess the knowledge and perception of both TB and DM of the participants was gotten through 
questionnaires. This study revealed that the total prevalence of diabetes mellitus was 29.7% while that of IFG 
was 16.5% amongst TB patients receiving care at the Bamenda Regional hospital compared to the 26.6% DM 
and 2.9% IFG for the control group. In total, 42(46.2%) of the test population were hyperglycemic (IFG/DM) 
compared to 16(23.5%) of the control group and this difference was statistically significant (p<0.05)  More 
males (28%) in this study were hyperglycemic than females ( 21%) but the difference was statistically not 
sgnificant,   26% of alcohol consumers were more hyperglycemic than non alcohol consumers and the 
difference was statistically significant ( p< 0.05). The age range of 31 – 40 years had the highest prevalence 
level ( 9%) of  DM  and 7% of IFG and those below 20 years had the lowest glycemic levels. Findings from this 
study revealed that TB patients had a higher prevalence of DM and IFG compared to the control population 
(sputum negative patients).  
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The screening of diabetes in patients with pulmonary tuberculosis is recommended for successful treatment, 
control and patient care of the two diseases.  
Keywords: Diabetes Mellitus; Impaired Fasting Glycemia; Pulmonary Tuberculosis; Bamenda Regional hospital 
– Cameroon. 
1. Introduction 
Diabetes mellitus (DM) is a carbohydrate metabolism disorder in which there is a high blood sugar level or 
hyperglycemia and it is caused by the absence of insulin or insulin function that allows the body to store 
glucose[1]. Type 1 DM, type 2 DM, other specific types of diabetes and gestational diabetes mellitus are the 4 
major types of diabetes and the other specific types of diabetes include those due to genetic disorders, infections, 
diseases of the exocrine pancreas, endocrinopathies, and drugs [1]. Persons with diabetes require intensive 
medical care to manage blood glucose levels and prevent complications due to diabetes such as cardiovascular 
diseases, retinopathy and neuropathy.[1]. Type 2 diabetes is characterized by insulin resistance and abnormal 
insulin secretion, either of which may predominate but both of which are usually present. The specific reasons 
for the development of these abnormalities are largely unknown. Type 2 is the most common type of diabetes. 
Type 2 diabetes can remain asymptomatic for many years, and the diagnosis is often made from associated 
complications or incidentally through an abnormal blood or urine glucose test. [1]. For the purpose of this study, 
type 2 DM will be the area of interest. The global prevalence has risen from 4.7% to 8.5% since the 1980s, and 
it was estimated that 422 million of adults were living with DM in 2014 [2]. This increase has been due to the 
accelerated rise of DM in low- and middle-income countries rather than in high-income countries [2]. By 2030, 
it is estimated that approximately 552 million people will be affected by the disease [2] Diabetes is a large cause 
of death and disability in Sub-Saharan Africa. The international Diabetes Federation (IDF) has estimated that 
the prevalence of diabetes in Sub-Saharan Africa as a whole for 2014 was approximately 10.6 [2]. Diabetes 
poses a large financial burden in countries with limited resources. For example, in Africa, where mean per 
capita expenditures on health are US$30–800, the mean annual cost for diabetes care ranges between $2144 and 
$11 430 (direct costs $876–1220) [20].    Tuberculosis (TB) remains a major cause of morbidity and mortality 
worldwide, with an estimated 10.4 million people newly developing TB and 1.7 million dying from it in 2016 
[21]. Over 70% of these new cases occurred in developing countries and the highest rate of death occurred in 
Africa. Tuberculosis (TB) is an infectious disease caused by the Mycobacterium complex, including M. 
tuberculosis (tubercle bacillus), M. bovis occurring worldwide and is a major public health problem. Most 
infections are asymptomatic or non-progressive [3]. The most common site of infection is the lungs (pulmonary 
TB) and is the main source of infection in the transmission of TB [3]. There is now abundant evidence of high 
rates of diabetes in people with Tuberculosis, and often diabetes is only discovered if screened for. The same is 
true for Tuberculosis  rates among people with diabetes. The growing burden of TB-DM is changing the 
landscape of TB care and prevention. Diabetes is a chronic, non-communicable disease that weakens the 
immune system, making people with diabetes three times more susceptible to active TB [4]. Worldwide, there 
are an estimated 9.6 million new patients with active TB annually and among  them, 1 million have both TB and 
DM (TB-DM) [4]. In the current scenario, the number of patients with TB-DM comorbidity is higher than the 
number of patients with TB-HIV co-infection around the world [4]. In Africa, studies investigating the 




prevalence of TB among persons with DM are limited. The few studies that have been performed show varying 
prevalence of DM in TB patients, ranging from 3%  to 36%, more than 5 folds greater than in the general 
population [21,22]. Routine screening of TB patients for DM is lacking in most African health facilities, 
somewhat because of cost, perceived complexities [23] and non-existent treatment infrastructure. The standard 
diagnostic methods present their own challenges. Patients are required to fast for several hours before fasting 
blood glucose (FBG), or the the oral glucose tolerance test (OGTT). Use of random blood glucose (RBG) and 
glycated haemoglobin (HbA1c) with the latter being more expensive, is sensitive, does not require the patient to 
fast and can be offered at point of care (POC) to minimize the time to diagnosis [24].  In Cameroon, there is 
very little or no information on the co-infection of TB and diabetes in patients. Thus studies to determine its 
prevalence is of outmost importance in order to undertake effective preventive measures and to improve on 
disease management[25].  The purpose of this research was therefore to determine the prevalence of Diabetes 
mellitus and impaired fasting glycemia in patients diagnosed of pulmonary TB attending the Bamenda Regional 
Hospital (BRH). This research is to create awareness about TB-DM coinfection and also a call to action to 
address this threat before it takes a larger toll in death and disability as well as economic impact. It also 
identifies where knowledge gaps should drive a research agenda, and how evaluation should be used to gauge 
progress and shape public policies [4].  
Main objective  
To determine the prevalence of Diabetes mellitus II and impaired fasting glycemia in patients diagnosed with 
pulmonary TB at the Bamenda Regional Hospital. 
Specific objectives  
 To determine the prevalence of Diabetes mellitus II and impaired fasting glycemia in TB patients 
receiving care at the Bamenda Regional hospital and to compare data with those of a control population 
(people who have a negative test result for TB).  
 To assess the prevalence of Diabetes mellitus II and impaired fasting glycemia in relation to age, 
gender, family history of diabetes and drug regimen.  
 To determine the prevalence of DM – TB comorbidity according to sociodemographic factors such as 
alcohol consumption, smoking, and literacy level.  
TB patients are unaware of the co-epidemic of DM-TB. Diabetes rates are skyrocketing worldwide, and having 
diabetes increases the risk that a person will become sick with TB [5]. A person sick with both diseases is likely 
to have complications that do not typically exist when either is present on its own. It was therefore the reason for 
this research, to determine and evaluate the number of TB patients with undiagnosed diabetic status by 
analyzing their blood sugar levels. The findings from this study could be used to create awareness through 
health talks and preventive measures to reduce complications which are due to the hyperglycemic environment, 
exposing the virulence of some pathogens in TB patients. 





Diabetes can be devastating to TB patients by adding more burdens to the chronic disease.  
Significance of Study  
The results of this study among TB patients will help in future studies which can help create awareness on the 
risk factors of Diabetes. The findings from this study could also be used for successful treatment, control and 
care of TB-DM patients. 
2. Materials and methods 
 2.1  Research design  
This was a prospective study conducted on the TB patients attending the Bamenda Regional Hospital (BRH). 
2.1.1 Study site  
This study was carried out at the Bamenda Regional Hospital (BRH), Northwest Region, and Cameroon. It is 
one of the 10 regional hospitals in Cameroon that serve as a second level referral hospital to the district hospitals 
and the polyclinics in the Northwest Region (NWR).  
It is situated in the Azire Health Area in the Bamenda Heath District. It serves as a teaching hospital to medical 
students, student nurses, laboratory science students and other students.  
2.1.2 Study population  
The study population included all TB patients attending the Bamenda Regional Hospital (BRH) who were 
willing to participate in the study. A total of 159 patients were sampled in this study  
2.1.3 Inclusion criteria  
All the TB patients attending the Bamenda Regional Hospital who gave their informed consent to completely 
answer the questionnaire, and accept for their samples to be collected for analysis 
2.1.4 Exclusion criteria  
Any TB patients who did not give his/her informed consent was excluded from this study. Pregnant women 
were also excluded because they were already prone to gestational diabetes due to pregnancy. Those who had 
eaten before the test were also excluded from the study. 
2.1.5 Instruments for data collection  




A semi-structured questionnaire was used, which contained both close and open ended questions. The 
questionnaire was used to collect both demographic and clinical data. It was administered to participants in 
person and the respondents were expected to fill at their convenience. Those who had difficulties in 
understanding or answering certain questions were assisted by the researcher. The data was keyed into a laptop 
and analyzed using Microsoft excel. Names of participant, date of collection, age of participant, sex of 
participant, and identification numbers were indicated on the Sodium fluoride oxalate tubes for all samples that 
were collected. In addition, the identification number on each tube for a particular participant was same as that 
on the respondent’s questionnaire sheets.  
2.1.6 Materials for data collection  
Blood samples were collected from each participant by venipuncture from the antecubital vein of the forearm 
using disposable syringes from which plasma glucose testing was determined. 2ml of blood was delivered into a 
clean, dry labeled sodium fluoride tube and taken to the laboratory for analysis. 
2.1.7 Sample analysis  
2.1.7.1 Biochemical analysis for blood glucose  
This was done using the CHRONOLAB SYSTEMS chemistry analyzer.[6]  
Test principle  
Glucose oxidase (GOD) catalyzes the oxidation of glucose to gluconic acid. The formed hydrogen peroxide is 
detected by a chromogenic oxygen acceptor, phenol-aminophenazone in the presence of peroxidase (POD). The 
color intensity formed is proportional to the glucose concentration in the sample.  
Procedure  
 Adjusted the instrument to zero with distilled water  
 Pipetted into cuvettes as follows:  
 Mixed and incubated for 10mins at 37 degrees or 20mins at room temperature  
 Read the absorbance (A) of the samples and standard, against the blank. The color change was stable 
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Expected results  
Normal range for Fasting plasma glucose:  60-110mg/dl  ~3.33-6.10 mmol/L [7]  
2.1.8 Statistical Analysis  
Descriptive statistical packages such as frequency tables, percentages and graphics was used to present research 
findings. The statistical package used for data analysis is the SPSS (Statistical Package for Social Sciences) 
Version 21.  
2.1.9 Ethical considerations  
An authorization to carry out this study was obtained from the North West regional delegation of public health 
with supporting clearance from the department of medical laboratory science of the University of Bamenda. 
Only patients who voluntarily accepted to participate were recruited in the study.  
3. Results  
3.1 Overview of study population  
This study consisted of 91 patients and 68 controls.  The patient group had more males than females and was 
more in the age range 31-40 years. About 70% of the patient population was HIV negative; more than 80% were 
smokers and had a history of alcohol consumption. Almost all patients did not have a family history of diabetes 
(97%); about 20% had attended at least primary education, and almost 20% of the patient group suffered from 
multiple drug resistant forms of TB.  The control group had more males than females and was more in the age 
group of 50 years and above; most of them (95%) were nonsmokers but had a history of alcohol consumption 
and a lot of them had a family history of diabetes (39%). About 16% had attended at least primary education. 
3.1.1 Prevalence of diabetes mellitus and IFG in patients versus control  





Figure 1: Prevalence of DM and IFG in test group 
Considering the 91 TB patients who participated in the study, 49(53.8%) had normal glucose levels, 27(29.7%) 
were diabetic and 15(16.5%) had IFG. (Fig 1)  
3.1.2 Prevalence of DM and IFG in test and control group 
 
Figure 2: Prevalence of DM and IFG in test and control group 
Considering the control group, 50(73.5%) had normal glucose levels, and 14(20.6) were diabetic, 2(2.9%) had 
IFG and 2(2.9%) were hypoglycemic and the difference was statistically significant ( P< 0.05). (Fig 2)  
3.1.3 Prevalence of diabetes mellitus  according to gender  
 
Figure 3: Prevalence of DM and IFG according to gender distribution 




The prevalence of DM and IFG was more in males compared to females, (p=0.023) (Fig 3). 
3.1.4 According to age range  
 
Figure 4: Prevalence of DM and IFG according to age range 
The prevalence of DM and IFG did not differ significantly in relation to age (p=0.26, Fig 4) 
3.1.5 According to Family history of Diabetes mellitus 
 
Figure 5: Prevalence of DM and IFG according to family history 
The prevalence of DM and IFG did not differ significantly in relation to family history of diabetes, (p=0.416, 
Fig 5) 
3.1.6 Prevalence of hyperglycemia according to alcohol consumption  





Figure 6: Prevalence of DM and IFG according to alcohol consumption 
The prevalence of DM and IFG differed significantly in relation to alcohol consumption, alcohol consumers 
were more hyperglycemic. (p=0.006, Fig 6 ) 
3.1.7 According to the literacy level 
 
Figure 7: Prevalence of hyperglycemia according to literacy level 
Glycemic levels did not differ in relation to literacy levels; however, patients at the university level tended to 
have better glycemic control when compared to those of lower levels, (p=0.051, Fig 7) 
3.1.8 In relation to smoking  
 
Figure 8: Prevalence of DM and IFG according to smoking 




The prevalence of DM and IFG did not differ significantly in relation to smoking, (p=0.389, Fig 8) In total, 
42(46.2%) of the test population were hyperglycemic (IFG/DM) compared to 16(23.5%) of the control group 
and this difference was statistically significant. (p<0.001). 
4. Discussion of findings  
The prevalence of DM and IFG in our study was 29.7% and 16.5% respectively compared to 26.6% and 2.9% 
for the control group.The results in this study were similar to that of  Balakrishnan and his colleagues of 
Southern India [9]. Reference [13] had emphasized that there is substantial evidence to support the fact that 
diabetes is an important risk factor for TB. They had a prevalence of 25.3% and 24.5% respectively for DM and 
IFG among TB patients in South India. The Chandigarh Urban Diabetes Survey (CUDS) through Ravikumar 
and his colleagues (2011) instead reported a lower prevalence of diabetes (11.1%) and IFG (13.2%) in North 
India and Barik and his colleagues (2016)  reported a much lower prevalence in Bengal of 2.95% and 3.34% 
respectively..  The high prevalence of DM and IFG obtained in this study is evidence that insulin dependence, 
and poor glycemic control predicts increased TB risk. Leung and his colleagues [10]. Reference [5] in studies 
carried out in Hong Kong, China, 2008 and in John Hopkins University, school of medicine,USA, 2009, on their 
part reported that the association between diabetes and TB is bidirectional because diabetes exerts a negative 
effect on the clinical course of TB with increased risk of treatment failure, relapse and death, while (Jeon and his 
colleagues [8] in a systematic review in India, 2010, revealed that,  TB exacerbates poor glycemic control in 
people with diabetes . Males in this study,  had higher DM (8%) than females (7%), and higher IFG, 16% and 
11% respectively although the difference was statistically insignificant (P=0.023). This could be because men 
are more consumers of alcohol and tobacco which are risk factors of this disease. Balakrishnan and his 
colleagues [9] had  similar findings stating that higher prevalence of DM among men than women might be an 
accumulative effect of other risk factors such as smoking, tobacco use and alcohol consumption, which impact 
both TB and DM.  This study also revealed that patient within the age range 31 - 40 years had  higher FBS 
values although the difference was not significant. This could be attributed to unhealthy diets, sedentary 
lifestyles and childhood and adult obesity. Corbett and his colleagues [15] and Raviglione and his colleagues 
(1992) [17]   in  studies carried out in western Europe, 2003,  had similar results stating that older age group 
from 40 years and above have an increased risk of DM and TB.and  maximum cases are in the age group of 60 
years and above which they postulated that the older age group are likely to develop diabetes due to depressed 
immune activity. Alcohol consumers were more hyperglycemic, (p= 0.006),showing that alcohol consumption 
was a significant factor in increasing FBS levels in the TB patients. This study has therefore revealed that 
gender, age, alcohol consumption and smoking had an accumulative effect on co-morbidity of DM and TB. 
Balakrishnan and his colleagues in a study , they carried out in Kerala, India,2012 presented similar results 
stating strongly that the higher prevalence of DM among men than women might be an accumulative effect of 
other risk factors such as smoking, tobacco use and alcohol consumption, which impact both TB and DM. , [9]  
This study did not record any significant relationship between family history of diabetes and hyperglycemia in 
TB positive patients. Similarly,in a study carried out by Silvera and his colleagues 2006,in Brazil, showed no 
association with family history [16]. Unlike a study carried out by Alfredo and his colleagues 2004, in Southern 
Mexico which showed an association of family history with DM/TB comorbidity. TB patients at the university 
level tended to have lower glycemic levels compared to those at primary or secondary levels. This could be 




explained by the fact that at lower education levels, respondents were not educated on the dangers of developing 
DM in TB for prevention through lifestyle modification. The studies by [2014] in India and Silveira and his 
colleagues in Southern Brazil [19] also obtained similar results which  found no significant association between 
level of education and frequency of DM/TM comorbidity.  
5. Limitations of the study 
Anthropometric measurements to calculate Body Mass Index ( BMI) to screen for obesity which is a 
predisposing factor for diabetes was not done. Sample size was reduced because TB patients who had eaten 
were excluded  from carrying out the diabetes tests which were Fasting Blood Sugar( FBS)  and Impaired 
Fasting glucose (IMG). Random Blood Sugar( RBS) was not done. The impact of this study was record based 
and the impact on treatment outcome of the co-morbidity was not done. 
6. Conclusion  
This study revealed that the prevalence of diabetes in pulmonary tuberculosis patients was higher than expected 
and the high proportion of DM patients among our study participants indicates low diabetes screening coverage 
in TB clinics. Also . the study revealed that the diseases had mainly affected the age group from 31 years and 
above thus reducing  the productive work force in this region of our Country, Cameroon. so it is important that 
there should prevention of DM through attention to unhealthy diets, sedentary lifestyles and childhood and adult 
obesity must be included in broad non-communicable disease prevention strategies. 
7. Recommendations  
These findings suggest that it is important for Cameroon Health Policy Makers to implement an integrated 
health service approach to address the burden of the two diseases. Our finding of a positive relationship between 
DM and TB thence highlights the need to screening TB patients for DM and vice versa, particularly in this 
North-Wes Region where there is lack of data on the occurrence of DM in TB. Appropriate and reliable 
prediabetes and diabetes screening methods and more screening Health centers should be put in place in order to  
reduce the risk of developing these diseases  and manage them at early stages. More studies are needed to 
further understand the relationships and treatment outcome approaches of TM- DM co-morbidity.  
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